5/2/2022U.S. FDA Snubs Two More China Only-Tested New Drugs from Hutchmed and ...

5/2/2022Merck's MilliporeSigma Invests €100M to Accelerate Single-Use Manufac...

4/29/2022BMS and Chinese Partner LianBio Won FDA Nod for Camzyos to Treat Hea...

4/29/2022NHSA and NHC Issue Notice to Improve National 6th VBP (Insulin Program...

4/29/2022Recent Executive Moves

4/29/2022Financial-related Company News Digest

4/29/2022Adagene-Sanofi's $2.5B Deal Tops March Deals in China (PharmaDJ)

4/28/2022Stevanato Group Acquires Manufacturing Facility in Zhejiang to Suppor...

4/28/2022Sales Expenditures of Listed Chinese Pharma Companies Sharply Up Again...

4/28/2022SMEI Revises Down Chinese Pharma Industry Growth Projection in 2022

4/28/2022Sanofi Reports Q1/2022 Performance, Witnessing 13.4% Growth in China

4/27/2022Xbiome Acquires Clinical-Stage Program Targeting Ulcerative Colitis

4/26/2022AstraZeneca Remain Bullish on Long-term Development in China

4/26/2022NMPA and Chinese Customs Announce Addition of Zhongshan City's Zhongsh...

4/26/2022AstraZeneca Plans Innovation Center for Traditional Chinese Medicines

4/26/2022China Clears Homegrown PD-1 Inhibitors for Solid Tumors (PharmaDJ's Ch...

4/25/2022AstraZeneca Withdraws Suits After SPC Sidesteps Review of "Reverse Pay...

4/22/2022Bayer Seeks Expanded Use of Prostate Cancer Drug Nubeqa in China

4/22/2022Recent Executive Moves

4/21/2022ATUM Accelerates Entry of Bioengineering Solutions into China

4/20/2022Joseph Romanelli Returns to Merck to Lead Human Health International A...

4/20/2022I-Mab Reportedly Weighing Options Including Sale: Bloomberg

4/20/2022PharmaDJ's China Biotech Fundraising Tracker: March 2022

4/20/2022China Commercial Health Insurance Opportunities

4/19/202234 HK-Listed Chinese Biopharma Firms Saw Sharp Revenue Growth in 2021 ...

4/18/2022VectorBuilder to Build $500M Gene Therapy Manufacturing Facility in Ch...

4/16/2022Opportunities and Challenges in China for Developing Oncology Drugs fo...

4/15/2022NMPA Issues the Guidelines for Pharmacovigilance Inspections

4/14/2022PhIIC: Chinese Retail Biologics Sales Led by Anti-tumor Drugs in 2021

4/13/2022China Meheco to Distribute Ascletis's Ritonavir Tablets in Mainland Ch...

Page:45/333 Total number of articles:9989: [First][<<] [43] [44] [45] [46] [47] [>>] [End]